REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,242,765 | -54.7% | 457,085 | 0.0% | 4.62% | -47.2% |
| Q2 2023 | $11,568,821 | -21.4% | 457,085 | 0.0% | 8.76% | +2.8% |
| Q1 2023 | $14,722,708 | +74.5% | 457,085 | 0.0% | 8.52% | +81.1% |
| Q4 2022 | $8,437,789 | -31.6% | 457,085 | 0.0% | 4.70% | -7.7% |
| Q3 2022 | $12,341,000 | +95.4% | 457,085 | 0.0% | 5.10% | +95.3% |
| Q2 2022 | $6,317,000 | -29.1% | 457,085 | 0.0% | 2.61% | +21.2% |
| Q1 2022 | $8,913,000 | +19.5% | 457,085 | 0.0% | 2.16% | +28.4% |
| Q4 2021 | $7,460,000 | -43.3% | 457,085 | -3.3% | 1.68% | -42.6% |
| Q3 2021 | $13,166,000 | -64.7% | 472,590 | -64.6% | 2.92% | -46.9% |
| Q2 2021 | $37,277,000 | -51.7% | 1,333,692 | -51.7% | 5.51% | -54.3% |
| Q1 2021 | $77,141,000 | -18.6% | 2,759,950 | -17.4% | 12.06% | -50.9% |
| Q4 2020 | $94,714,000 | +12.7% | 3,342,047 | 0.0% | 24.58% | -44.9% |
| Q3 2020 | $84,019,000 | +2.9% | 3,342,047 | 0.0% | 44.64% | +11.5% |
| Q2 2020 | $81,613,000 | +65.0% | 3,342,047 | 0.0% | 40.04% | +25.7% |
| Q1 2020 | $49,462,000 | -8.8% | 3,342,047 | 0.0% | 31.84% | +25.9% |
| Q4 2019 | $54,241,000 | +24.8% | 3,342,047 | 0.0% | 25.30% | -6.5% |
| Q3 2019 | $43,447,000 | +0.2% | 3,342,047 | 0.0% | 27.06% | +8.3% |
| Q2 2019 | $43,346,000 | -17.7% | 3,342,047 | 0.0% | 24.99% | -4.7% |
| Q1 2019 | $52,671,000 | -42.6% | 3,342,047 | 0.0% | 26.22% | -28.2% |
| Q4 2018 | $91,739,000 | +10.5% | 3,342,047 | 0.0% | 36.54% | +111.6% |
| Q3 2018 | $83,050,000 | -9.5% | 3,342,047 | 0.0% | 17.27% | -18.9% |
| Q2 2018 | $91,739,000 | -22.5% | 3,342,047 | -13.0% | 21.30% | -17.8% |
| Q1 2018 | $118,335,000 | -13.8% | 3,842,047 | 0.0% | 25.90% | +4.3% |
| Q4 2017 | $137,353,000 | +8.6% | 3,842,047 | -16.3% | 24.83% | +10.6% |
| Q3 2017 | $126,511,000 | +4.4% | 4,592,047 | 0.0% | 22.44% | +2.4% |
| Q2 2017 | $121,230,000 | +26.9% | 4,592,047 | 0.0% | 21.92% | +0.6% |
| Q1 2017 | $95,515,000 | +0.5% | 4,592,047 | 0.0% | 21.79% | +0.5% |
| Q4 2016 | $95,055,000 | +27.7% | 4,592,047 | 0.0% | 21.68% | +40.0% |
| Q3 2016 | $74,437,000 | +19.2% | 4,592,047 | 0.0% | 15.49% | -1.6% |
| Q2 2016 | $62,452,000 | -22.1% | 4,592,047 | 0.0% | 15.74% | -25.0% |
| Q1 2016 | $80,177,000 | -48.9% | 4,592,047 | 0.0% | 20.98% | -26.9% |
| Q4 2015 | $156,864,000 | +14.8% | 4,592,047 | 0.0% | 28.69% | +14.8% |
| Q3 2015 | $136,659,000 | -6.9% | 4,592,047 | 0.0% | 24.98% | -5.8% |
| Q2 2015 | $146,854,000 | +54.3% | 4,592,047 | 0.0% | 26.51% | +40.4% |
| Q1 2015 | $95,193,000 | +22.4% | 4,592,047 | 0.0% | 18.88% | -22.2% |
| Q4 2014 | $77,789,000 | -12.4% | 4,592,047 | 0.0% | 24.28% | -24.9% |
| Q3 2014 | $88,764,000 | -43.1% | 4,592,047 | 0.0% | 32.32% | -0.5% |
| Q2 2014 | $156,130,000 | +7.9% | 4,592,047 | 0.0% | 32.47% | -11.8% |
| Q1 2014 | $144,649,000 | – | 4,592,047 | – | 36.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |